timing is everything. As to Warren Buffet he represents everything wrong with America today.
What's your timeline for long term investors? I find timelines on this board are seriously manipulated as well.
Pacritinib like Jakafi is another symptomatic treatment... perhaps with less side effects but no real competition with Imet's secondary endpoints. Sure it's nice to get a smaller spleen but wouldn't longevity be better? J&J planned this up coming trial's #1 primary endpoint to challenge symptomatic responses and it's #2 secondary endpoint to establish CR's & PRs making it superior to both Pacritinib or Jakafi
Please Lord give us this day a daily gain in GERN. Amen!
that was a spell check from the previous post I made. I meant competition for Jakafi if approved for spleen endpoints. IMET will outperform both with their secondary endpoint results.
Suck on your thumbs church lady
you have a point, no direct news seems to spike price. They lift SP at will without news and then short down from there as they did back in March with the two 25mil share vol days spiking SP up into the $4.50's two days later, Jocko was jazzing all over the board with his PCYC knickers in a knot
13 million right after the private placement with Fidelity. The it fell back down to 9mil riht before the hold. 24-30 million ever since.
You've posted in the wrong church. People here only want to discuss GERN's phase ll trials not some spleen only pacritinib drug. All said it's all good for Jakafi to finally get some completion. If enough new better drugs come on line INCY wont be able to delay the changing tide. Seeking and getting are two different animals
I agree maybe it's time for MEIP to rally after June's new trial results. "Pracinostat, a potential best-in-class, oral HDAC inhibitor currently being developed for advanced hematologic diseases, such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Full data from the Company's Phase II study of Pracinostat in combination with azacitidine in elderly patients with newly diagnosed AML are expected in June 2015"
the fact that retail is all holding cash makes me think we shall see another rally. Wall Street wouldn't allow such an opp to slip by. After that all bets are off.
I have her 'real' address but she never would respond thinking she might actually be someone else in the real world. I'm suspect her hubby has waited so long for the next transfusion whilst his status has diminished from CR to PR and yet still can't/won't receive another transfusion. WRT GERN she certainly separates church and state when it comes to science and her personal investments. I'm convinced she(if in fact wasn't a hoax) had very little invested in GERN, if any at all.
you'll lose your shirt playing options here kpail. Don't encourage others to do the same unless of course you're a MM writing them yourself and that's how you make money.
well then get Irish trader to help you set up an MPN forum for Imet to counter Jakafi's. I visited the site only a few times in 2 years. Never helped me guess the timing wrt to my GERN investment. Still down over 30% 18 months later when I thought Fidelity's placement pullback was over and loaded up for the multi testing phase ll that was to have been scheduled for last year June. Some(FDA) had some other plans shortly after which no forum could possibly forewarn me about. June is next week and we'll see if your forum can guess the new trial's exact start. Your efforts would be served much better if u published who is behind the 26 mil shorted shares in Gern. It would answer many questions.
Most doctors I know invest in private equities where such SP manipulation gaming is non existent. They look for secure companies with high performance, not the roulette wheel we see here in GERN.